Last reviewed · How we verify
NCT03763435
The Effects of Pregnancy Classes and Contributing Factors to Postpartum Depression
trial testing Antenatal pregnancy classes in Postpartum Depression in 400 participants. Status unknown.
15 June 2019
Quick facts
| Lead sponsor | Bartin State Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 7 December 2018 |
| Primary completion | 15 June 2019 |
| Estimated completion | 15 July 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Antenatal pregnancy classes
Conditions studied
- Postpartum Depression — all drugs for Postpartum Depression →
- Sleep Disorder — all drugs for Sleep Disorder →
- Breast Feeding — all drugs for Breast Feeding →
- Self Esteem — all drugs for Self Esteem →
Sponsor
Bartin State Hospital
Who can join
Eligibility, female only, with Postpartum Depression or Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is recommended by the American College of Obstetricians and Gynecologists' Committee on Obstetric Practice that all obstetricians screen each women for postpartum depression and anxiety with a validated instrument. Although much effort is made, the contributing factors still lack in the literature due to its multi-factorial nature and complexity. In addition, the effects of prenatal education classes remain understudied. Therefore, this study aims to demonstrate the prevalence, characteristics and contributing factors of the postpartum depression. In addition, the change in prevalence and characteristics of the postpartum depression among women who had prenatal classes and not will also be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03763435
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postpartum Depression
Currently open trials in the same condition.
- NCT07398469 — A Long-Term Study of Patient-Reported Changes in Postpartum Depression Symptoms in People Starting Zuranolone · recruiting
- NCT06442774 — MamaConecta: Digital Tool for Maternal Mental Health · NA · recruiting
- NCT06545760 — Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression · NA · recruiting
- NCT05763537 — Understanding the Role of Doulas in Supporting People With PMADs · NA · recruiting
- NCT06462638 — COntact RElationship in Neonatal Intensive Care Unit · recruiting
Other Bartin State Hospital trials
Trials by the same sponsor.
- NCT03832244 — The Role of Sub-mental Ultrasonography in Diagnosing Obstructive Sleep Apnea and Its Correlation With Subjective Scales · completed
- NCT03830502 — Driving Factors of Decision Making for Prophylactic Salpingectomy Versus Tubal Ligation at the Time of Cesarean Section · completed
- NCT03763071 — Sleep Disturbances in the 2nd and 3rd Trimester · completed
- NCT03763097 — Sonographic Evaluation of the Single-incision Needleless (Contasure-needleless®) Mini-sling Placement to Predict Success · completed
- NCT03754621 — Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03763435 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bartin State Hospital
- Last refreshed: 23 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03763435.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing